Pogestomon cablin

From Epilepsy Naturapedia
Revision as of 14:10, 21 March 2013 by Media wiki admin (Talk | contribs) (Created page with "right == Nomenclature== === Other Names:=== == Historical Use of Pogestomon cablin== === Pogestomon cablin in Traditional Chinese Medicine=== ==Background==...")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Tcm94.jpg

Nomenclature

Other Names:

Historical Use of Pogestomon cablin

Pogestomon cablin in Traditional Chinese Medicine

Background

Guanghuoxiang ¹ãÞ½Ïã Houxianggeng Þ½Ïã¹£ Huoxiangye Þ½ÏãÒ¶ Xianhuoxiang ÏÊÞ½Ïã Chinese Name (pinyin): Huoxiang

Chinese Name  :

Common Name  :Agastache

Specific Name  : Herba Agastachis

Scientific Name:
Collection  :

Description  :

Identification  :

Processing  :

Action  :

Indication  :

Precautions  :

Dosage  : 6-12g for decocted/15-30 for fresh

Storage  :

Synonymns for Pogestomon cablin

Patent Medicines and Medicines with Multiple Ingredients that include Pogestomon cablin

Pharmaceutical Information

Chemical Constituents

Evidence or the Use of Pogestomon cablin in the Treatment of Epilepesy

Basic Science

Animal Studies

Cohort, Case-Control and Non-Randomized Trials

Randomized Controlled Trials

Meta-Analysis

1st Five Results: pubmed search

Yuchan Chen, Nuoyi Wang, Weipeng Ma, Wei Gu, Zihuan Sang, Haibo Tan, Weimin Zhang, Hongxin Liu
Irpexols A-C, xanthone derivatives from the endophyte fungus Irpex laceratus A878.
Fitoterapia: 2024;105952
[PubMed:38614405] [WorldCat.org] [DOI] (I a)

Wenguang Shi, Junyan Li, Siyun Xie, Xing Wang, Yuxin Zhang, Huaxiong Yao, Meiqi Chen, Jianbin Li, Zujun Deng
##Title##
Plant Dis: 2024;PDIS09231722RE
[PubMed:38613135] [WorldCat.org] [DOI] (P a)

Shiqiang Xu, Fangping Li, Fang Zhou, Jingyu Li, Shike Cai, Shaohai Yang, Jihua Wang
##Title##
Hortic Res: 2024, 11(3);uhae021
[PubMed:38469380] [WorldCat.org] [DOI] (P e)

Shengzhao Tang, Shangyi Huang, Jiaxin Huang, Xinger Lai, Jingyi Guo, Jiawen Huang, Yanhua Zhong
Pogostone attenuated high-fat diet-induced nonalcoholic fatty liver disease in mice through inhibition of NLRP3 inflammasome signaling.
Eur J Pharmacol: 2024, 970;176463
[PubMed:38461909] [WorldCat.org] [DOI] (I p)

Puyue Ouyang, Dali Kang, Weijing You, Xiaozhong Shen, Xiaolu Mo, Yao Liu
##Title##
Front Nutr: 2024, 11;1303002
[PubMed:38419848] [WorldCat.org] [DOI] (P e)

Safety

Allergies

Side Effect and Warnings

Pregnancy and Breastfeeding

Adverse Effects